Giovanni MD - Bristol Myers Chairman CEO
| BMY Stock | MXN 1,222 16.45 1.36% |
Insider
Giovanni MD is Chairman CEO of Bristol Myers Squibb
| Age | 58 |
| Phone | 212 546 4000 |
| Web | https://www.bms.com |
Bristol Myers Management Efficiency
The company has return on total asset (ROA) of 0.0613 % which means that it generated a profit of $0.0613 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1846 %, meaning that it generated $0.1846 on every $100 dollars invested by stockholders. Bristol Myers' management efficiency ratios could be used to measure how well Bristol Myers manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Fabian Bifaretti | Grupo Sports World | 59 | |
| Samantha Hammock | Verizon Communications | 44 | |
| Mark Hall | Monster Beverage Corp | 63 | |
| Susie Cranston | First Republic Bank | N/A | |
| Alain Bellemare | Delta Air Lines | 62 | |
| Gary Fayard | Monster Beverage Corp | 67 | |
| JD III | Capital One Financial | 56 | |
| Jennifer Smoter | UnitedHealth Group Incorporated | N/A | |
| Andrew Young | Capital One Financial | 48 | |
| Emelie Tirre | Monster Beverage Corp | 53 | |
| Zachary Sopcak | UnitedHealth Group Incorporated | N/A | |
| Jeanne Jackson | Monster Beverage Corp | 67 | |
| John Laughter | Delta Air Lines | 52 | |
| James Barry | UnitedHealth Group Incorporated | 77 | |
| Timothy Schmidt | Prudential Financial | 64 | |
| James Gerace | Verizon Communications | 59 | |
| Guy Carling | Monster Beverage Corp | 46 | |
| Matthew Friedrich | UnitedHealth Group Incorporated | 53 | |
| D Wilson | UnitedHealth Group Incorporated | 60 | |
| Daniel Janki | Delta Air Lines | 54 | |
| Michael Ioanilli | First Republic Bank | N/A | |
Management Performance
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0613 |
Bristol Myers Squibb Leadership Team
Elected by the shareholders, the Bristol Myers' board of directors comprises two types of representatives: Bristol Myers inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bristol. The board's role is to monitor Bristol Myers' management team and ensure that shareholders' interests are well served. Bristol Myers' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bristol Myers' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jitendra Tyagi, Head India | ||
| Cari Gallman, VP Officer | ||
| David Elkins, Ex CFO | ||
| BCH BM, Ex Devel | ||
| Giovanni MD, Chairman CEO | ||
| Greg Meyers, Ex Officer | ||
| Ann Judge, Senior Vice President - Global Human Resources | ||
| Sandra Esq, Exec Counsel | ||
| Timothy Power, VP Relations | ||
| Christopher Boerner, Executive Vice President and Chief Commercial Officer |
Bristol Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bristol Myers a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0613 | |||
| Profit Margin | 0.14 % | |||
| Operating Margin | 0.20 % | |||
| Current Valuation | 3.9 T | |||
| Shares Outstanding | 2.13 B | |||
| Shares Owned By Insiders | 0.06 % | |||
| Shares Owned By Institutions | 78.98 % | |||
| Price To Earning | 254.74 X | |||
| Price To Book | 5.23 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Bristol Stock Analysis
When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.